| Bliss GVS Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506197 |
NSE Symbol : BLISSGVS |
P/E(TTM) : 60.44 |
|
ISIN Demat : INE416D01022 |
Div & Yield% : 0.15 |
EPS(TTM) : 10.90 |
|
Book Value(₹) : 108.59 |
Market Cap(₹Cr) : 7,008.58 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 221.59 | 211.54 | 164.68 | 190.23 | 163.36 | 156.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 221.59 | 211.54 | 164.68 | 190.23 | 163.36 | 156.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 8.76 | 9.66 | 10.23 | 13.59 | 10.59 | 9.36 |
| Total Income | 230.35 | 221.20 | 174.91 | 203.82 | 173.96 | 165.36 |
| Total Expenditure | 169.72 | 167.39 | 140.34 | 159.96 | 130.60 | 142.27 |
| PBIDT | 60.63 | 53.81 | 34.57 | 43.86 | 43.36 | 23.09 |
| Interest | 0.39 | 1.81 | 1.48 | 2.71 | 5.11 | 1.30 |
| PBDT | 60.24 | 52.00 | 33.09 | 41.15 | 38.25 | 21.79 |
| Depreciation | 9.03 | 7.84 | 7.80 | 7.69 | 7.68 | 7.43 |
| Tax | 9.29 | 11.06 | 7.52 | 11.41 | 12.55 | 3.95 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.30 | 0.68 | -0.84 | -2.75 | -3.04 | -1.04 |
| Reported Profit After Tax | 38.62 | 32.42 | 18.61 | 24.79 | 21.05 | 11.45 |
| Extra-ordinary Items | 0.00 | 0.26 | -1.77 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 38.62 | 32.16 | 20.38 | 24.79 | 21.05 | 11.45 |
| EPS (Unit Curr.) | 3.65 | 3.06 | 1.76 | 2.35 | 2.00 | 1.08 |
| EPS (Adj) (Unit Curr.) | 3.65 | 3.06 | 1.76 | 2.35 | 2.00 | 1.08 |
| Calculated EPS (Unit Curr.) | 3.64 | 3.06 | 1.76 | 2.35 | 2.00 | 1.09 |
| Calculated EPS (Adj) (Unit Curr.) | 3.64 | 3.06 | 1.76 | 2.35 | 2.00 | 1.09 |
| Calculated EPS (Ann.) (Unit Curr.) | 14.57 | 12.26 | 7.04 | 9.39 | 7.98 | 4.35 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 14.57 | 12.26 | 7.04 | 9.39 | 7.98 | 4.35 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 50.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.61 | 10.58 | 10.58 | 10.56 | 10.55 | 10.54 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 27.36 | 25.44 | 20.99 | 23.06 | 26.54 | 14.80 |
| PBDTM(%) | 27.19 | 24.58 | 20.09 | 21.63 | 23.41 | 13.97 |
| PATM(%) | 17.43 | 15.33 | 11.30 | 13.03 | 12.89 | 7.34 |
